{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:37:02Z","timestamp":1790303822736,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.3129\/i09-061","type":"journal-article","created":{"date-parts":[[2009,9,29]],"date-time":"2009-09-29T13:15:01Z","timestamp":1254230101000},"page":"e9-e12","source":"Crossref","is-referenced-by-count":47,"title":["Infliximab for the treatment of active scleritis"],"prefix":"10.1016","volume":"44","author":[{"given":"H. Nida","family":"Sen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Sangave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri","family":"Hammel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Levy-Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Nussenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3129\/i09-061_bib1","series-title":"Ocular Infection and Immunity","first-page":"642","article-title":"Scleritis and episcleritis.","author":"McCluskey","year":"1996"},{"key":"10.3129\/i09-061_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00163549","article-title":"The natural history of uveitis","volume":"14","author":"Nussenblatt","year":"1990","journal-title":"Int Ophthalmol"},{"key":"10.3129\/i09-061_bib3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/bjo.75.6.340","article-title":"Use of cyclosporin in the management of steroid dependent non-necrotising scleritis","volume":"75","author":"Hakin","year":"1991","journal-title":"Br J Ophthalmol"},{"key":"10.3129\/i09-061_bib4","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0161-6420(84)34160-4","article-title":"Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression","volume":"91","author":"Foster","year":"1984","journal-title":"Ophthalmology"},{"key":"10.3129\/i09-061_bib5","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0161-6420(92)31790-7","article-title":"Low-dose methotrexate therapy for ocular inflammatory disease","volume":"99","author":"Shah","year":"1992","journal-title":"Ophthalmology"},{"key":"10.3129\/i09-061_bib6","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0161-6420(03)00570-0","article-title":"Mycophenolate mofetil for the treatment of scleritis","volume":"110","author":"Sen","year":"2003","journal-title":"Ophthalmology"},{"key":"10.3129\/i09-061_bib7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.3129\/i09-061_bib8","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archopht.123.7.903","article-title":"A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes","volume":"123","author":"Suhler","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.3129\/i09-061_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00002281-200207000-00001","article-title":"Anterior uveitis: current concepts of pathogenesis and interactions with the spondyloarthropathies","volume":"14","author":"Martin","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.3129\/i09-061_bib10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jlb.61.6.667","article-title":"Expression of TNF-alpha by human plasma cells in chronic inflammation","volume":"61","author":"Di Girolamo","year":"1997","journal-title":"J Leukoc Biol"},{"key":"10.3129\/i09-061_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000090010","article-title":"Expression of tumor necrosis factor alpha and matrix metalloproteinase-9 in surgically induced necrotizing scleritis","volume":"38","author":"Seo","year":"2006","journal-title":"Ophthalmic Res"},{"key":"10.3129\/i09-061_bib12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/archopht.122.6.845","article-title":"Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis","volume":"122","author":"Murphy","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.3129\/i09-061_bib13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0161-6420(03)00721-8","article-title":"Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis","volume":"111","author":"Murphy","year":"2004","journal-title":"Ophthalmology"},{"key":"10.3129\/i09-061_bib14","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0161-6420(03)00406-8","article-title":"Infliximab in the treatment of refractory posterior uveitis","volume":"110","author":"Joseph","year":"2003","journal-title":"Ophthalmology"},{"key":"10.3129\/i09-061_bib15","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/sj.eye.6701712","article-title":"Anti-TNF alpha therapy in chronic necrotizing scleritis resistant to standard immunomodulatory therapy in a patient with Wegener's granulomatosis","volume":"19","author":"El-Shabrawi","year":"2005","journal-title":"Eye"},{"key":"10.3129\/i09-061_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/09273940701299370","article-title":"A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Beh\u00e7et's disease","volume":"15","author":"Buggage","year":"2007","journal-title":"Ocul Immunol Inflamm"},{"key":"10.3129\/i09-061_bib17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.3129\/i09-061_bib18","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0161-5890(93)90106-L","article-title":"Construction and initial characterization of a mouse-human chimeric anti-TNF antibody","volume":"30","author":"Knight","year":"1993","journal-title":"Mol Immunol"},{"key":"10.3129\/i09-061_bib19","first-page":"219","article-title":"Guidelines for treatment with infliximab for Crohn's disease","volume":"64","author":"Hommes","year":"2006","journal-title":"Neth J Med"},{"key":"10.3129\/i09-061_bib20","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ajo.2004.04.066","article-title":"Infliximab for chronic cystoid macular edema associated with uveitis","volume":"138","author":"Markomichelakis","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.3129\/i09-061_bib21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.7326\/0003-4819-140-5-200403020-00025","article-title":"Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Beh\u00e7et disease","volume":"140","author":"Sfikakis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.3129\/i09-061_bib22","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/S0161-6420(02)01292-7","article-title":"Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis","volume":"109","author":"El-Shabrawi","year":"2002","journal-title":"Ophthalmology"},{"key":"10.3129\/i09-061_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/sj.tpj.6500091","article-title":"Pharmacogenetic investigation of the TNF\/TNF-receptor system in patients with chronic active Crohn's disease treated with infliximab","volume":"2","author":"Mascheretti","year":"2002","journal-title":"Pharmacogenomics J"},{"key":"10.3129\/i09-061_bib24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2036.2004.01946.x","article-title":"Tumour necrosis factoralpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab","volume":"20","author":"Pierik","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.3129\/i09-061_bib25","first-page":"679","article-title":"Occurrence of pulmonary thromboembolism during infliximab therapy","volume":"21","author":"Eklund","year":"2003","journal-title":"Clin Exp Rheumatol"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418209802263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418209802263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T09:57:42Z","timestamp":1542707862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418209802263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0008418209802263"],"URL":"https:\/\/doi.org\/10.3129\/i09-061","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}